4.7 Article

Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production

期刊

EMBO REPORTS
卷 20, 期 6, 页码 -

出版社

WILEY
DOI: 10.15252/embr.201847451

关键词

COUP-TFII; glycolysis; KRAS; lactate; mTORC1

资金

  1. National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017M3A9G7073086, NRF-2018R1A2A1A05077703]
  2. NRF - Ministry of Education [NRF-2017R1A6A3A04010231]
  3. Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI16C1501]
  4. National Research Foundation of Korea [2017M3A9G7073086] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Oncogenic signals contribute to enhanced glycolysis and mTORC1 activity, leading to rapid cell proliferation in cancer. Regulation of glycolysis and mTORC1 by PI3K/Akt signaling is well established, but how KRAS-induced MEK signaling regulates these pathways remains poorly understood. Here, we report a role for MEK-driven lactate production in mTORC1 activation in KRAS-activated cells. KRAS/MEK-induced upregulation of the chicken ovalbumin upstream promoter transcriptional factor II (COUP-TFII) increases the expression of lactate dehydrogenase A (LDHA), resulting in lactate production and mTORC1 activation. Further, lactate inhibits the interaction of TSC2 and Rheb, leading to the cellular activation of mTORC1 irrespective of growth factor stimulation. These findings suggest that COUP-TFII is a novel oncogenic mediator, connecting KRAS signaling and glycolysis, and leading to mTORC1 activation and cellular growth.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据